Sriram Ramaswamy is a Psychiatry physician. ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3528 Dodge St
Omaha, NE 681313202
Telephone
402-345-8828Provider last certified this registry record 14 Dec 2020.
Clinical trials
- Minocycline for Treatment of Posttraumatic Stress Disorder in Veterans
Sponsor: Sriram Ramaswamy
- Decision Aid to Facilitate Shared Decision Making During Treatment in Schizophrenia
Sponsor: VA Nebraska Western Iowa Health Care System
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alkermes, Inc.Program year202516 payments$12,766openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year20241 payment
- ABBVIE INC.Program year20234 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
94.8%SSRI22.4%Sertraline Hcl40%Trazodone Hcl19%Escitalopram Oxalate19%Fluoxetine Hcl17%Fluvoxamine Maleate7%Part D<11 patientsAtypical Antipsychotic11%Quetiapine Fumarate55%Olanzapine17%Aripiprazole15%Risperidone12%Part D<11 patients+ 14 more classes in this area
Cardiovascular
3.8%Central alpha-2 Adrenergic Agonist2.1%Clonidine Hcl100%Part D<11 patientsalpha-Adrenergic Blocker1.7%Prazosin Hcl100%Part D<11 patientsMetabolism & gastrointestinal
1.3%Proton pump inhibitor1.3%Pantoprazole Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Scheltens
Inserm
Rafael Tabarés‐Seisdedos
Universitat de València
Nick C. Fox
UK Dementia Research Institute
Perminder S. Sachdev
Department of Health and Aged Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”